By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Immunomedics, Inc. 

300 American Road

Morris Plains  New Jersey  07950-2450  U.S.A.
Phone: 201-605-8200 Fax: 973-605-8282



Company News
Immunomedics, Inc. (IMMU) Provides Update On Phase 2 Study Of Isactuzumab Govitecan In Patients With Diverse Metastatic Solid Cancers 10/30/2014 7:22:15 AM
Immunomedics, Inc. (IMMU) To Present Updated Clinical Results With Solid-Tumor Antibody-Drug Conjugates At Upcoming Conferences 10/22/2014 7:24:15 AM
Immunomedics, Inc. (IMMU) Announces European Orphan Drug Designation For Isactuzumab Govitecan For Pancreatic Cancer Treatment 10/20/2014 7:22:29 AM
Immunomedics, Inc. (IMMU) Announces Presentations At The 2014 European Association Of Nuclear Medicine Congress 10/13/2014 8:10:06 AM
Immunomedics, Inc. (IMMU) Publishes Results On Immunotherapy Of Solid Cancers Mediated By A Novel Bispecific Antibody 9/26/2014 7:32:59 AM
Immunomedics, Inc. (IMMU) Announces Fiscal 2014 Results And Clinical Program Developments 8/26/2014 7:23:49 AM
Immunomedics, Inc. (IMMU) Announces Conference Call And Webcast For Fourth Quarter And Fiscal Year 2014 Financial Results 8/11/2014 7:46:30 AM
Immunomedics, Inc. (IMMU) Release: Scientific Data On Epratuzumab In Systemic Lupus Erythematosus To Be Presented At EULAR 2014 6/9/2014 9:11:24 AM
Immunomedics, Inc. (IMMU) Announces Orphan Drug Designation For IMMU-132 For Pancreatic Cancer Therapy 6/9/2014 8:59:56 AM
Immunomedics, Inc. (IMMU) Reports Development Of Improved Cancer Immunotherapy At The 2014 Annual Meeting Of The American Society of Clinical Oncology 6/2/2014 9:50:09 AM